SightfileU.S. market data from official filings

BIODESIX INC (BDSX)

Name: BIODESIX INC (BDSX) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001439725 · EDGAR filings · Updated 2026-07-02

BIODESIX INC (BDSX) has reported institutional ownership of 35.8%, with 40 institutional managers holding positions valued at $52.4M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

35.8%

Institutional managers

Reported 13F value

$52.4M

Insider activity

81 trans.

$4.58M net buying

Data flags

2 active

from SEC filings

Latest updates

2026-07-02 — Insider transaction reported (Form 4)
2026-06-18 — SCHEDULE 13G filed
2026-06-01 — Prospectus supplement (424B3) filed
2026-05-29 — EFFECT filed
2026-05-21 — Shelf registration (S-3) filed
2026-05-20 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, BIODESIX INC has 40 institutional holders and institutional ownership of 35.8%.

Insider activity

Insiders reported 81 transactions (7 buys, 25 sells) across 10 reporting insiders, with a net reported value of $4.58M.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-03-28 (recurring since 2025-03-28) — source filing. The authoritative details are those stated in the filing itself.

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2025-03-03 (recurring since 2021-11-15) — source filing. The authoritative details are those stated in the filing itself.

Related companies

OUTSET MED INC (OM) · MDXHEALTH SA (MDXH) · Inovio Pharmaceuticals Inc (INO) · MESOBLAST LTD (MESO) · SPRUCE BIOSCIENCES INC COM NEW (SPRB) · Spero Therapeutics Inc (SPRO)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.